7 unknown. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Unknown 7 |
| Phase 1 | 2 | Unknown 2 |
Follow ADHD: new trials by email Literature Review of ADHD trials Research Report on ADHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Black Seed Oil in ADHD Atomoxetine, Black Seed Oil Cap/Tab - ADHD | Phase 2 | Unknown | Ain Shams University | 60 | 2024-10-01 | 2024-08-09 |
| Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective Potassium Gluconate Oral Capsule, Placebo oral capsule - ADHD | Phase 1 / Phase 2 | Unknown | AlkaliDx, Inc. | 100 | 2018-07-01 | 2018-06-20 |
| Neurofeedback Study ADHD NF, SM, PE - ADHD | Phase 2 | Unknown | Philipps University Marburg | 120 | 2011-01-01 | 2016-11-15 |
| Repetitive Transcranial Magnetic Stimulation in Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts repetitive Transcranial Magnetic Stimulation (rTMS) - Cognition Disorders, Cocaine Dependence | Phase 2 | Unknown | University of Sao Paulo General Hospital | 40 | 2010-03-01 | 2012-05-23 |
| Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD) Cognitive remediation and Parent Training - ADHD | Phase 2 | Unknown | Queens College, The City University of New York | 84 | 2009-09-01 | 2012-11-14 |
| PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children PS-Omega3 conjugate supplementation, placebo - ADHD | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 45 | 2008-07-01 | 2008-06-18 |
| Intervening Early With Neglected Children Attachment and Biobehavioral Catch-up, Developmental Education for Families - Conduct Disorder, ADHD | Phase 1 / Phase 2 | Unknown | University of Delaware | 220 | 2005-03-01 | 2020-11-17 |
Attention Deficit Disorder with Hyperactivity (7) · Cocaine-Related Disorders (1) · Cognition Disorders (1) · Conduct Disorder (1) · Depression (1) · Neuroinflammatory Diseases (1)
Attention Deficit and Disruptive Behavior Disorders (7) · Mental Disorders (7) · Neurodevelopmental Disorders (7) · Behavior (1) · Behavioral Symptoms (1) · Chemically-Induced Disorders (1) · Inflammation (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Substance-Related Disorders (1)
Atomoxetine Hydrochloride (1) · Cognitive Remediation (1) · Transcranial Magnetic Stimulation (1)
Ain Shams University (1) · AlkaliDx, Inc. (1) · Philipps University Marburg (1) · Queens College, The City University of New York (1) · Tel-Aviv Sourasky Medical Center (1) · University of Delaware (1) · University of Sao Paulo General Hospital (1)
United States (3) · Brazil (1) · Germany (1) · Israel (1)
Anil Chacko, PhD (1) · Debora Arnaut, PSYD (1) · Mark Mintz, MD (1) · Mary Dozier, Ph.D. (1) · Michael M Segal, MD PhD (1) · Nachum Vaisman, Prof' (1)
PMID 24117656, PMID 25436448, PMID 25505396, PMID 30659782, PMID 31677152, PMID 32731812, PMID 32781397, PMID 36061275, PMID 36548042, PMID 37385583